Bangladesh is fast emerging as the next destination for investment in Healthcare & Pharma - a place where breakthrough solutions can be developed cost-effectively, scaled rapidly, and exported to markets increasingly embracing Bangladesh’s brand of world-class healthcare and pharmaceutical innovation.

Last Thursday, SAJIDA Foundation was honored to co-sponsor the Healthcare & Pharma session at the Bangladesh Investment Summit 2025 - in partnership with Bangladesh Investment Development Authority - BIDA, Eastern Bank PLC. and Inspira Advisory & Consulting Limited - and reinforce our commitment to building an innovative, cost-effective, and scalable healthcare system.

Our CEO, Zahida Fizza Kabir, joined industry leaders and session partners to launch the report “Bangladesh’s Healthcare Sector Coming of Age,” spotlighting a projected market growth to $23bn by 2030.

Key Takeaways from Industry Leaders and Investors:

• Innovation in R&D: Emphasis on advancing bio-equivalent drug research with Bangladesh’s significant cost advantage.
• Tertiary Care: Urgent need for investment in high-quality healthcare infrastructure.
• Investor Confidence: Focus on clear exit strategies through IP ownership and export-driven innovation.
• Regional Biohub: Bangladesh is poised to be a leading center for biologistics, testing, and biotech.